Wuhan Hiteck Biological Pharma Co.,Ltd. Posted 12.8 Million Yuan Net Loss in First Half of 2023

Wuhan Hiteck Biological Pharma Co.,Ltd. (武汉海特生物制药股份有限公司) (300683.SZ) reported a net loss of 12.8 million yuan in the first half of 2023, reversing a net profit of 25.3 million yuan for the same period in the previous year.

Meanwhile, the company posted 286.4 million yuan in revenue, down 26% year-on-year.

At the end of the reporting period, it had 2.9 billion yuan in total assets and 328.9 million yuan in total liabilities, with a liability-to-asset ratio of 11.2%.